Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings C

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript February 22, 2024 Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome […]

Related Keywords

Laura Sepp Lorenzino , Maury Raycroft , Glenn Goddard , , New England Journal , Intellia In Vivo , Chief Scientific Officer , Recode Therapeutics , Allo Solution , Chief Financial Officer , Wind Power , Solar Stocks To Buy , Growing Economies , John Leonard , Intellia Therapeutics , David Lebwohl , Chief Executive Officer , Perator Instructions , Rispr , Fourth Quarter ,